(2R)-anti-5-(3-(4-(10,11-difluoromethanodibenzo-suber-5-yl)piperazin-1-yl)2-hydroxypropoxy)quinoline trihydrochloride,
LY 335979,
LY335979,
RS 33295-198,
RS-33295-198,
zosuquidar trihydrochloride,
167465-36-3,
Zosuquidar Trihydrochloride,
Ly335979,
Zosuquidar HCl,
LY 335979,
RS-33295-198,
LY335979 (Zosuquidar 3HCL),
Zosuquidar 3HCl,
Zosuquidar (trihydrochloride),
UNII-813AGY3126,
LY-335979,
Zosuquidar (LY335979) 3HCl,
LY335979 trihydrochloride,
Zosuquidar trihydrochloride (USAN),
Zosuquidar Trihydrochloride [USAN],
813AGY3126,
NCGC00274062-01,
cc-68,
AC1L4BI9,
DSSTox_CID_31451,
DSSTox_RID_97337,
DSSTox_GSID_57662,
cc-286,
LY-335979 trihydrochloride,
C32H34Cl3F2N3O2,
CHEMBL2074689,
DTXSID1057662,
RS 33295-198 trihydrochloride,
EX-A2191,
Tox21_113964,
MFCD00942300,
s1481,
AKOS025293500,
AN-4953,
CS-0275,
RL02147,
(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol trihydrochloride,
(R)-4-((1aR,6R,10bS)-1,2-Difluoro-1,1a,6,10b-tetrahydrodibenzo(a,e)cyclopropa(c)cycloheptan-6-yl)-alpha-((5-quinoloyloxy)methyl)-1-piperazineethanol, trihydrochloride,
BC225603,
HY-50671,
LY335979 (Zosuquidar trihydrochloride),
LY335979 - Zosuquidar trihydrochloride,
CAS-167465-36-3,
FT-0675935,
SW219884-1,
Y0325,
D06387,
S-7710,
465L363,
J-500909,
RS 33295-198 (D06387) 3HCl,
Zosuquidar trihydrochloride; LY-335979 trihydrochloride,
LY335979, Zosuquidar, RS-33295-198, 167465-36-3,
(?R)-4-[(1a?,6?,10b?)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-?-[(5-quinolinyloxy)methyl]-1-piperazineethanol trihydrochloride,
(2R)-1-{4-[(1aR,6R,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-y loxy)propan-2-ol trihydrochloride,
(2R)-1-{4-[(2R,4S,11S)-3,3-difluorotetracyclo[10.4.0.0^{2,4}.0^{5,10}]hexadeca-1(12),5(10),6,8,13,15-hexaen-11-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol trihydrochloride,
(R)-1-(4-((1aR,6r,10bS)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-yl)piperazin-1-yl)-3-(quinolin-5-yloxy)propan-2-ol trihydrochloride,
(R)-4-((1aR,6R,10bS)-1,2-Difluoro-1,1a,6,10b-tetrahydrodibenzo(a,e)cyclopropa(c)cycloheptan-6-yl)-alpha-((5-quinoloyloxy)methyl)-1-piperazineethanol trihydrochloride,
1-Piperazineethanol, 4-(1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo(a,e)cyclopropa(c)cycloheptan-6-yl)-alpha-1((5-quinolinyloxy)methyl-, trihydrochloride, (6(R)-(1alpha,6alpha,10balpha))-,
Zosuquidar,
Zosuquidar (TN),
D06DCL,
CID153997,
C32-H31-F2-N3-O2.3Cl-H,
A8549,
RS 33295-198,
C095179,
Zosuquidar trihydrochloride, RS-33295-198, LY335979,
(2R)-anti-5-(3-(4-(10,11-difluoromethanodibenzo-suber-5-yl)piperazin-1-yl)2-hydroxypropoxy)quinoline trihydrochloride,
1-Piperazineethanol, 4-[(1aa,6a,10ba)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-a-[(5-quinolinyloxy)methyl]-,trihydrochloride,
167354-41-8,